ISRCTN25324586已完成不适用
A double-blind placebo-controlled randomised clinical trial to study the effect of Probiotics for the prevention or amelioration of Antibiotic Associated Diarrhoea in residents of care homes in South Wales and England
Cardiff University (UK)0 个研究点目标入组 400 人开始时间: 2013年3月14日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Resident in a care home for 24 hours or more, with a minimum planned period of residential care of 1 month
- •2. Able to provide informed consent or have a personal legal representative who can provide consent for inclusion
- •3. If the service users (SU) takes a regular probiotic but chooses to discontinue the probiotic
排除标准
- •1. Severely immuno-compromised, e.g. known severe neutropenia
- •2. Has artificial heart valve in situ
- •3. Medical history of acute pancreatitis
- •4. Requires naso-jejunal feeding /nasogastric feeding currently has a colostomy
- •5. SU without capacity already receiving a probiotic
研究者
相似试验
已完成
不适用
A double-blind placebo-controlled randomised clinical trial assessing the efficacy and safety of a novel herbal formulation for weight loss in an Australian population of healthy adults who are overweight.OverweightAlternative and Complementary Medicine - Herbal remediesACTRN12621000470897Southern Cross University110
进行中（未招募）
1 期
A research study investigating semaglutide in people with early Alzheimer’s disease (EVOKE plus)Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s typeMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2020-004864-25-IEovo Nordisk A/S1,840
进行中（未招募）
1 期
A research study investigating semaglutide in people with early Alzheimer’s disease (EVOKE)Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s typeMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2020-004848-29-DEovo Nordisk A/S1,840
进行中（未招募）
1 期
A research study investigating semaglutide in people with early Alzheimer’s disease (EVOKE)EUCTR2020-004848-29-PLovo Nordisk A/S1,840
进行中（未招募）
3 期
A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer diseaseJPRN-jRCT2031210117Ohsugi Toshiaki139